Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT00303108

Public ClinicalTrials.gov record NCT00303108. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 7:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Doxil and Carboplatin, Plus Herceptin in HER2+ Patients, in Metastatic Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the ORR associated with Doxil in combination with carboplatin in HER2- (negative) MBC (and with Herceptin in HER2+ MBC).

Study identification

NCT ID
NCT00303108
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
US Oncology Research
Industry
Enrollment
136 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2005
Primary completion
Feb 28, 2010
Completion
May 31, 2011
Last update posted
Nov 2, 2016

2005 – 2011

United States locations

U.S. sites
57
U.S. states
20
U.S. cities
54
Facility City State ZIP Site status
Birmingham Hematology and Oncology Birmingham Alabama 35205
Hematology Oncology Associates Phoenix Arizona 85012
Northern AZ Hematology & Oncology Associates-Sedona Sedona Arizona 86336
Rocky Mountain Cancer Center-Rose Denver Colorado 80220
Florida Cancer Institute New Port Richey Florida 34655
Ocala Oncology Center Ocala Florida 34474
Hematology Oncology Associates of IL Chicago Illinois 60611
Cancer Care & Hematology Specialists of Chicagoland, PC Niles Illinois 60714
Central Indiana Cancer Centers Indianapolis Indiana 46227
Kansas City Cancer Centers-Southwest Overland Park Kansas 66210
Maryland Oncology Hematology, PA Columbia Maryland 21044
Flavio Kruter, MD, PA Westminster Maryland 21157
Minnesota Oncology Hematology, PA Minneapolis Minnesota 55404
Missouri Cancer Associates Columbia Missouri 65201
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109
New Mexico Cancer Care Associates Santa Fe New Mexico 87505
New York Oncology Hematology, PC Albany New York 12208
Ruth Oratz MD New York New York 10016
Raleigh Hematology Oncology Associates Cary North Carolina 27511
Greater Dayton Cancer Center Kettering Ohio 45409
Willamette Vallejy Cancer Center Eugene Oregon 97401
Medical Oncology Associates Kingston Pennsylvania 18704
Texas Cancer Center - Abilene (South) Abilene Texas 79606
Texas Oncology, P.A.-Amarillo Amarillo Texas 79106
Texas Cancer Center Arlington Texas 76014
Mamie McFaddin Ward Cancer Center Beaumont Texas 77702
Texas Oncology, PA-Bedford Bedford Texas 76022
Texas Cancer Center at Medical City Dallas Texas 75230
Texas Oncology, PA Dallas Texas 75231
The TexasCancer Center Dallas Texas 75237
Texas Oncology, PA Dallas Texas 75246
Texas Cancer Center-Denton Denton Texas 76210
El Paso Cancer Treatment Ctr El Paso Texas 79915
Texas Oncology, PA Fort Worth Texas 76104
Texas Oncology, PA Garland Texas 75042
Texas Oncology, PA Houston Texas 77024
Lake Vista Cancer Center Lewisville Texas 75067
Longview Cancer Center Longview Texas 75601
South Texas Cancer Center-McAllen McAllen Texas 78503
Texas Cancer Center of Mesquite Mesquite Texas 75150
Alison Cancer Center Midland Texas 79701
West Texas Cancer Center Odessa Texas 79761
Paris Regional Cancer Center Paris Texas 75460
HOAST-Medical Dr. San Antonio Texas 78229
Texas Cancer Center-Sherman Sherman Texas 75090
Texas Oncology Cancer Center-Sugar Land Sugar Land Texas 77479
Tyler Cancer Center Tyler Texas 75702
Texas Oncology Cancer Care and Research Center-Waco Waco Texas 76712
Texas Oncology, P.A. Webster Texas 77598
Fairfax Northern VA Hem-Onc PC Fairfax Virginia 22031
Virginia Oncology Associates Norfolk Virginia 23502
Onc and Hem Associates of SW VA, Inc Salem Virginia 24153
Puget Sound Cancer Center-Edmonds Edmonds Washington 98026
Puget Sound Cancer Center-Seattle Seattle Washington 98133
Cancer Care Northwest-North Spokane Washington 99218
Northwest Cancer Specialists-Vancouver Vancouver Washington 98684
Yakima Valley Mem Hosp/North Star Lodge Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00303108, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2016 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00303108 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →